Literature DB >> 7970731

The MAP kinase phosphorylation site of TAL1 occurs within a transcriptional activation domain.

I A Wadman1, H L Hsu, M H Cobb, R Baer.   

Abstract

Alteration of the TAL1 gene is the most common genetic lesion found in patients with T cell acute lymphoblastic leukemia. TAL1 encodes a basic helix-loop-helix transcription factor that is phosphorylated on serine residue 122 by the mitogen-activated protein (MAP) kinase ERK1. Here we show that the amino-terminal sequences of TAL1 (residues 1-166) function in vivo as a transcriptional activation domain. Mutation of serine residue 122 reduces the potency of the transactivation domain by more than half. The data suggest that the amino-terminal transactivation domain of TAL1 is positively regulated by S122 phosphorylation and that the functional properties of TAL1 can be influenced by signal transduction pathways that involve the MAP kinases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7970731

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.

Authors:  Y Li; C Deng; X Hu; B Patel; X Fu; Y Qiu; M Brand; K Zhao; S Huang
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

2.  An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.

Authors:  P D Aplan; C A Jones; D S Chervinsky; X Zhao; M Ellsworth; C Wu; E A McGuire; K W Gross
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

3.  MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates.

Authors:  R Fukunaga; T Hunter
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

4.  Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation of the TAL1/SCL transcription factor in murine proerythroblasts.

Authors:  T Tang; K S Prasad; M J Koury; S J Brandt
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

5.  Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase.

Authors:  A M Whalen; S C Galasinski; P S Shapiro; T S Nahreini; N G Ahn
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

6.  Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1.

Authors:  H Osada; G Grutz; H Axelson; A Forster; T H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

7.  Control of lytic function by mitogen-activated protein kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: identification of perforin and granzyme B mobilization by functional ERK2.

Authors:  S Wei; A M Gamero; J H Liu; A A Daulton; N I Valkov; J A Trapani; A C Larner; M J Weber; J Y Djeu
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

Review 8.  GATA2 +9.5 enhancer: from principles of hematopoiesis to genetic diagnosis in precision medicine.

Authors:  Alexandra A Soukup; Emery H Bresnick
Journal:  Curr Opin Hematol       Date:  2020-05       Impact factor: 3.218

9.  Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression.

Authors:  Benjamin Uzan; Sandrine Poglio; Bastien Gerby; Ching-Lien Wu; Julia Gross; Florence Armstrong; Julien Calvo; Xavier Cahu; Caroline Deswarte; Florent Dumont; Diana Passaro; Corinne Besnard-Guérin; Thierry Leblanc; André Baruchel; Judith Landman-Parker; Paola Ballerini; Véronique Baud; Jacques Ghysdael; Frédéric Baleydier; Francoise Porteu; Francoise Pflumio
Journal:  EMBO Mol Med       Date:  2014-04-06       Impact factor: 12.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.